Production of curcumin by engineered Escherichia coli.
- Author:
Le ZHANG
1
;
Ning DING
1
;
Yan HAI
1
;
Yaru YAN
1
;
Na LI
1
;
Sainan LI
1
;
Pengfei TU
1
;
Xiao LIU
1
;
Shepo SHI
1
Author Information
- Publication Type:Journal Article
- Keywords: Escherichia coli; curcumin; engineered bacteria; non-natural fusion protein
- MeSH: Curcumin/pharmacology*; Escherichia coli/genetics*; Fermentation
- From: Chinese Journal of Biotechnology 2021;37(6):2077-2084
- CountryChina
- Language:Chinese
- Abstract: Curcumin is exclusively isolated from Zingiberaceae plants with a broad spectrum of bioactivities. In the present study, we used the diketide-CoA synthase (DCS) and curcumin synthase (CURS) genes to construct a non-natural fusion gene encoding diketide-CoA synthase::curcumin synthase (DCS::CURS). This fusion protein, together with the acetyl coenzyme A carboxylase (ACC) and the 4-coumarate coenzyme A ligase (4CL), were introduced into Escherichia coli for the production of curcumin from ferulic acid. The process is divided into two stages, the growth stage using LB medium and the fermentation stage using the modified M9 medium. The yield of curcumin reached 386.8 mg/L by optimizing the induction of protein expression in the growth stage, and optimizing the inoculum volume, medium composition and fermentation time in the fermentation stage, as well as the addition of macroporous resin AB-8 into the second medium to attenuate the toxicity of the end product. The exploitation of the non-natural fusion protein DCS::CURS for the production of curcumin provides a new alternative to further promoting the production of curcumin and the related analogues.
